tirzepatide trial In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Cardiovascular outcomes of semaglutide and

Why Women in Menopause & Perimenopause Struggle With Weight Loss During perimenopause and menopause , estrogen and progesterone levels fluctuate, impacting metabolism, fat storage, and insulin response

GLP-1 drugs appear to touch many of those pathways simultaneously

Presumed sulfa allergy in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality

10 Depression can be treated with antidepressants that are categorized into five groups, including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), serotonin-norepinephrine reuptake inhibitors, and non-TCA antidepressants